<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Immunic Inc (IMUX)</title>
    <description>Latest news, press releases, and SEC filings for Immunic Inc (IMUX)</description>
    <link>https://caymanjournal.com/stock/IMUX</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 21:43:06 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/IMUX/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>8-K — IMMUNIC, INC.</title>
      <description># 🧾 What This Document Is
This is an **8-K filing**, a &quot;current report&quot; that companies must file with the SEC to announce major events that shareholders should know about. Immunic is announcing a **1-for-10 reverse stock split** of its common stock. The filing includes the official legal amendment </description>
      <link>https://caymanjournal.com/stock/IMUX/sec-filing/0001193805-26-000495</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/IMUX/sec-filing/0001193805-26-000495</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>10-K/A — IMMUNIC, INC.</title>
      <description># 📰 What This Document Is 📂
This document is an Amendment No. 1 to Immunic, Inc.&apos;s Annual Report on Form 10-K. Think of a 10-K as the company&apos;s comprehensive, required annual report card, and this amendment is like a correction—it&apos;s being filed to update and include critical corporate governance i</description>
      <link>https://caymanjournal.com/stock/IMUX/sec-filing/0001193805-26-000493</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/IMUX/sec-filing/0001193805-26-000493</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>8-K — IMMUNIC, INC.</title>
      <description># 🧾 What This Document Is
This is an 8-K filing, which is a report companies use to announce major news to investors. In this case, Immunic is sharing official notice from Nasdaq that it has fixed a problem and is no longer at risk of being removed from the stock exchange.

# 🚨 The Core Announceme</description>
      <link>https://caymanjournal.com/stock/IMUX/sec-filing/0001193805-26-000382</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/IMUX/sec-filing/0001193805-26-000382</guid>
      <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>8-K — IMMUNIC, INC.</title>
      <description># 🔖 What This Document Is
This is an **8-K filing**, which is a report a company files with the SEC to announce major, shareholder-affecting news. In this case, **Immunic, Inc. (IMUX)** is announcing a key addition to its leadership team. Think of it as a formal press release with regulatory weight</description>
      <link>https://caymanjournal.com/stock/IMUX/sec-filing/0001193805-26-000370</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/IMUX/sec-filing/0001193805-26-000370</guid>
      <pubDate>Tue, 31 Mar 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>